COSMOS HEALTH INC (COSM) Stock Earnings & Estimates
USA - NASDAQ:COSM - US2214133058 - Common Stock
1.08 USD
-0.01 (-0.92%)
1.0698 USD
-0.01 (-0.94%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 50.35M -10.47% | 53.377M 6.01% | 54.426M 1.97% | 69.743M 28.14% | |
| EBITDA YoY % growth | -7.37M -75.89% | -21.217M -187.88% | -14.004M 34.00% | 3.56M 125.42% | |
| EBIT YoY % growth | -7.47M -64.54% | -21.831M -192.25% | -15.253M 30.13% | 571.2K 103.74% | |
| Operating Margin | -14.84% | -40.90% | -28.02% | 0.82% | |
| EPS YoY % growth | N/A | N/A | N/A -21.88% | 0.01 101.28% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.01 106.80% | -0.01 97.73% | 0.04 144.44% |
| Revenue Q2Q % growth | 17.825M 34.97% | 16.728M 34.78% | 19.38M 36.25% |
| EBITDA Q2Q % growth | 1.117M 159.76% | 632.4K 148.54% | 1.652M 122.25% |
| EBIT Q2Q % growth | -367.2K 85.32% | -112.2K 94.99% | 912.9K 110.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 72.18% | -0.03 | % | |
| Q4 2024 Q2Q % growth | 55.00% | -0.09 | % | |
| Q3 2024 Q2Q % growth | -0.45 | -0.11 | -0.34 | -301.07% |
| Q2 2024 Q2Q % growth | -0.15 | -0.14 | -0.01 | -5.04% |
| Q1 2024 Q2Q % growth | -0.11 | -0.14 | 0.03 | 22.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 13.713M -5.98% | 15.81M | -2.098M | -13.27% |
| Q4 2024 Q2Q % growth | 14.224M -10.20% | 14.79M | -565.8K | -3.83% |
| Q3 2024 Q2Q % growth | 12.411M -3.22% | 14.28M | -1.869M | -13.09% |
| Q2 2024 Q2Q % growth | 13.207M 6.85% | 15.555M | -2.348M | -15.09% |
| Q1 2024 Q2Q % growth | 14.584M 18.09% | 14.841M | -257K | -1.73% |
| Q4 2023 Q2Q % growth | 15.84M 31.45% | 14.025M | 1.815M | 12.94% |
| Q3 2023 Q2Q % growth | 12.824M 6.69% | % | ||
| Q2 2023 Q2Q % growth | 12.36M -6.43% | % | ||
| Q1 2023 Q2Q % growth | 12.35M -5.51% | % | ||
| Q4 2022 Q2Q % growth | 12.05M -25.53% | % | ||
| Q3 2022 Q2Q % growth | 12.02M -11.62% | % | ||
| Q2 2022 Q2Q % growth | 13.21M -11.04% | % | ||
| Q1 2022 Q2Q % growth | 13.07M 12.48% | % | ||
| Q4 2021 Q2Q % growth | 16.18M -0.74% | % | ||
| Q3 2021 Q2Q % growth | 13.6M -5.23% | % | ||
| Q2 2021 Q2Q % growth | 14.85M 15.83% | % | ||
| Q1 2021 Q2Q % growth | 11.62M -2.60% | % | ||
| Q4 2020 Q2Q % growth | 16.3M 38.25% | % | ||
| Q3 2020 Q2Q % growth | 14.35M 48.09% | % | ||
| Q2 2020 Q2Q % growth | 12.82M 50.65% | % | ||
| Q1 2020 Q2Q % growth | 11.93M 23.24% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |